U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 18:03:06 UTC 2023
Edited
by admin
on Sat Dec 16 18:03:06 UTC 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
IT063R5MY0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EPTOTERMIN ALFA
EMA EPAR   INN   MART.   WHO-DD  
INN  
Official Name English
EPTOTERMIN ALFA [EMA EPAR]
Common Name English
OSIGRAFT
Brand Name English
BONE MORPHOGENETIC PROTEIN 7
Common Name English
HBMP7
Brand Name English
eptotermin alfa [INN]
Common Name English
EPTOTERMIN ALFA [MART.]
Common Name English
OSTEOGENIC PROTEIN 1
Common Name English
HUMAN RECOMBINANT BONE MORPHOGENETIC PROTEIN 7
Common Name English
RH-POLYPEPTIDE-52
INCI  
INCI  
Official Name English
BMP-7
Common Name English
OP-1
Common Name English
RH-POLYPEPTIDE-52 [INCI]
Common Name English
OPGENRA
Brand Name English
Eptotermin Alfa [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC M05BC02
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
WHO-VATC QM05BC02
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
EMA ASSESSMENT REPORTS OPGENRA (AUTHORIZED: SPONDYLOLISTHESIS)
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
EMA ASSESSMENT REPORTS OSIGRAFT (AUTHORIZED: TIBIAL FRACTURES)
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
Code System Code Type Description
CAS
129805-33-0
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
DRUG CENTRAL
5175
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
EVMPD
SUB20066
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
INN
7989
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
ChEMBL
CHEMBL2108594
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
MESH
D055419
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
SMS_ID
100000089545
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
NCI_THESAURUS
C170404
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
FDA UNII
IT063R5MY0
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
DRUG BANK
DB11631
Created by admin on Sat Dec 16 18:03:07 UTC 2023 , Edited by admin on Sat Dec 16 18:03:07 UTC 2023
PRIMARY
From To
1_38 1_104
1_67 1_136
1_71 1_138
1_103 2_103
2_38 2_104
2_67 2_136
2_71 2_138
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_10
N 1_29
N 1_80
N 2_10
N 2_29
N 2_80
Related Record Type Details
TARGET -> AGONIST
Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.
TARGET -> AGONIST
Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL